RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024
REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4%
PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS
RECORDATI: PRELIMINARY RESULTS FOR FULL YEAR 2024 REVENUE +12.4%, EBITDA(1) +12.5%, ADJUSTED NET INCOME(2) +8.4% PEAK YEAR SALES TARGETS RAISED FOR KEY RARE DISEASES PRODUCTS
Seeking Alpha / 2 hours from now 1 Views
Comments